Nirman Agri Genetics Ltd
₹ 195
1.27%
03 Jul
9:49 a.m.
About
Incorporated in 2020, Nirman Agri Genetics Ltd is in the business of manufacturing and processing seeds[1]
Key Points
- Market Cap ₹ 156 Cr.
- Current Price ₹ 195
- High / Low ₹ 484 / 177
- Stock P/E 6.18
- Book Value ₹ 137
- Dividend Yield 1.02 %
- ROCE 35.2 %
- ROE 34.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.9%
Cons
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 4 | 13 | 29 | 63 | 237 | |
| 4 | 10 | 24 | 52 | 210 | |
| Operating Profit | 0 | 3 | 4 | 11 | 27 |
| OPM % | 2% | 25% | 15% | 18% | 11% |
| 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 0 | 3 | 4 | 11 | 26 |
| Tax % | 29% | 25% | 6% | 5% | 3% |
| 0 | 3 | 4 | 10 | 25 | |
| EPS in Rs | 5.01 | 13.00 | 31.57 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 160% |
| TTM: | 273% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 115% |
| TTM: | 143% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 33% |
| Last Year: | 34% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 6 | 6 | 8 |
| Reserves | 0 | 3 | 21 | 31 | 102 |
| 1 | 1 | 1 | 1 | 0 | |
| 1 | 2 | 2 | 6 | 3 | |
| Total Liabilities | 2 | 6 | 30 | 44 | 113 |
| 0 | 0 | 1 | 0 | 2 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 2 | 6 | 29 | 44 | 111 | |
| Total Assets | 2 | 6 | 30 | 44 | 113 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -0 | 0 | 0 | 5 | -31 | |
| 0 | -0 | -21 | -2 | 9 | |
| 1 | 0 | 20 | -1 | 46 | |
| Net Cash Flow | 1 | 0 | -1 | 1 | 24 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 58 | 114 | 52 | 67 | 58 |
| Inventory Days | 21 | 25 | 76 | 61 | 66 |
| Days Payable | 40 | 38 | 6 | 39 | 1 |
| Cash Conversion Cycle | 39 | 101 | 121 | 89 | 123 |
| Working Capital Days | 32 | 81 | 91 | 79 | 111 |
| ROCE % | 133% | 27% | 34% | 35% |
Documents
Announcements
-
Structural Digital Database
1 July 2025 - Submission of SDD Compliance Certificate for year ended March 31, 2025 as per SEBI regulations.
-
Updates
30 June 2025 - Nirman Agri Genetics opts for half-yearly financial reporting from June 30, 2025 quarter onwards.
-
Resignation
5 June 2025 - Resignation of Independent Director Ms. Riddhi Nitin Aher effective May 30, 2025 disclosed.
-
Copy of Newspaper Publication
2 June 2025 - Newspaper publication of audited financial results for year ended March 31, 2025.
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
31 May 2025 - NIRMAN AGRI GENETICS LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Business Overview:[1]
a) NAGL is an agricultural input company that produces, processes, and markets premium hybrid seeds, organic fertilizers, and bio-organic seeds for a variety of crops, including corn, sunflower, cotton, rice, sorghum, and grain.
b) It has recently started producing micronutrients and bioproducts.
c) In addition, it grows non-hybrid seeds.
d) Company is working towards creating seeds with greater yield potential, drought resistance, pest and disease tolerance, etc.
e) It is also working on research and development projects about better breeding techniques and biotechnology instruments, which allows it to create hybrid seeds, micronutrients, and bioproducts.